Acta Biomater 93:192199 Vogiatzi G, Oikonomou E, Siasos G, Tsalamandris S, Briasoulis A, Androulakis E, Latsios G, Papaioannou S, Tsioufis K, Tousoulis D (2017) Statins and inflammation in cardiovascular disease
In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
(2) Supplement with -3 PUFAs (EPA + DHA 13 g/day) to inhibit the production of pro-inflammatory factors
A bonus is that Heather makes you comfortable with ice, numbing cream, and devices to keep your mind occupied during the injecting